2 terminated, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Withdrawn 1 |
Follow Hepatoma: new trials by email Literature Review of Hepatoma trials Research Report on Hepatoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HepATocellular Cancer Hcv Therapy Study Elbasvir / Grazoprevir Oral Tablet - Hepatocellular Carcinoma, Hepatoma | Phase 3 | Withdrawn | Bayside Health | 2019-09-01 | 2020-09-14 | |
| A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma DEB-TACE, Sorafenib - Hepatocellular Carcinoma, Hepatoma | Phase 3 | Terminated | Boston Scientific Corporation | 2 | 2015-11-01 | 2021-02-12 |
| Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma PI-88, placebo - Cancer, Liver Cancer | Phase 3 | Terminated | Progen Pharmaceuticals | 600 | 2007-12-01 | 2011-06-15 |
Carcinoma, Hepatocellular (3) · Hepatitis C (1) · Liver Neoplasms (1) · Neoplasms (1)
Adenocarcinoma (3) · Carcinoma (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Liver Diseases (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Glandular and Epithelial (3) · Liver Neoplasms (2) · Neoplasms (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1)
Sorafenib (1) · elbasvir-grazoprevir drug combination (1) · phosphomannopentaose sulfate (1)
Bayside Health (1) · Boston Scientific Corporation (1) · Progen Pharmaceuticals (1)
United States (2) · Australia (1) · Canada (1) · Hong Kong (1) · Italy (1) · Malaysia (1) · Singapore (1) · Spain (1) · Taiwan (1) · Thailand (1)
Anastasia Becker (1) · Ronnie TP Poon, MD (1)